Trial intelligence / Profile preview

Dexmedetomidine versus propofol on intestinal barrier function in major gastrointestinal surgery

TCTR20230118002Phase 4Unknown

Sponsor
King Chulalongkorn Memorial Hospital
Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dexmedetomidine, propofol in Gastrointestinal surgical condition, sponsored by King Chulalongkorn Memorial Hospital. Status: unknown.

02

Drugs

dexmedetomidinepropofol
03

Conditions

Gastrointestinal surgical condition

Beyond the preview

Go deeper on TCTR20230118002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20230118002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call